Can the current monkeypox affect the heart? A systematic review of case series and case report

Abstract Background Monkeypox is a zoonotic viral infection first reported in May 2022. Monkeypox cases present with prodromal symptoms, rash, and/or systemic complications. This study systematically reviews the monkeypox cases presented with any cardiac complications. Methods A systematic literatur...

Full description

Bibliographic Details
Main Authors: Reem Sayad, Abdelmonem Siddiq, Ahmed Hashim, Ahmed Saad Elsaeidy
Format: Article
Language:English
Published: BMC 2023-06-01
Series:BMC Cardiovascular Disorders
Subjects:
Online Access:https://doi.org/10.1186/s12872-023-03351-3
_version_ 1797789952969277440
author Reem Sayad
Abdelmonem Siddiq
Ahmed Hashim
Ahmed Saad Elsaeidy
author_facet Reem Sayad
Abdelmonem Siddiq
Ahmed Hashim
Ahmed Saad Elsaeidy
author_sort Reem Sayad
collection DOAJ
description Abstract Background Monkeypox is a zoonotic viral infection first reported in May 2022. Monkeypox cases present with prodromal symptoms, rash, and/or systemic complications. This study systematically reviews the monkeypox cases presented with any cardiac complications. Methods A systematic literature search was done to locate papers that discuss any cardiac complications associated with monkeypox; then, data were analyzed qualitatively. Results Nine articles, including the 13 cases that reported cardiac complications of the disease, were included in the review. Five cases previously had sex with men, and two cases had unprotected intercourse, which reveals the importance of the sexual route in disease transmission. All cases have a wide spectrum of cardiac complications, such as acute myocarditis, pericarditis, pericardial effusion, and myopericarditis. Conclusion This study clarifies the potential for cardiac complications in monkeypox cases and provides avenues for future research to determine the underlying mechanism. Also, we found that the cases with pericarditis were treated with colchicine, and those with myocarditis were treated with supportive care or cardioprotective treatment (Bisoprolol and Ramipril). Furthermore, Tecovirimat is used as an antiviral drug for 14 days.
first_indexed 2024-03-13T01:57:18Z
format Article
id doaj.art-44bd38cb217a45e6bf95009a08b7db83
institution Directory Open Access Journal
issn 1471-2261
language English
last_indexed 2024-03-13T01:57:18Z
publishDate 2023-06-01
publisher BMC
record_format Article
series BMC Cardiovascular Disorders
spelling doaj.art-44bd38cb217a45e6bf95009a08b7db832023-07-02T11:06:40ZengBMCBMC Cardiovascular Disorders1471-22612023-06-0123111110.1186/s12872-023-03351-3Can the current monkeypox affect the heart? A systematic review of case series and case reportReem Sayad0Abdelmonem Siddiq1Ahmed Hashim2Ahmed Saad Elsaeidy3Faculty of Medicine, Assiut UniversityFaculty of Pharmacy, Mansoura UniversityFaculty of Medicine, Ain Shams UniversityFaculty of Medicine, Benha UniversityAbstract Background Monkeypox is a zoonotic viral infection first reported in May 2022. Monkeypox cases present with prodromal symptoms, rash, and/or systemic complications. This study systematically reviews the monkeypox cases presented with any cardiac complications. Methods A systematic literature search was done to locate papers that discuss any cardiac complications associated with monkeypox; then, data were analyzed qualitatively. Results Nine articles, including the 13 cases that reported cardiac complications of the disease, were included in the review. Five cases previously had sex with men, and two cases had unprotected intercourse, which reveals the importance of the sexual route in disease transmission. All cases have a wide spectrum of cardiac complications, such as acute myocarditis, pericarditis, pericardial effusion, and myopericarditis. Conclusion This study clarifies the potential for cardiac complications in monkeypox cases and provides avenues for future research to determine the underlying mechanism. Also, we found that the cases with pericarditis were treated with colchicine, and those with myocarditis were treated with supportive care or cardioprotective treatment (Bisoprolol and Ramipril). Furthermore, Tecovirimat is used as an antiviral drug for 14 days.https://doi.org/10.1186/s12872-023-03351-3MonkeypoxMpoxCardiomyopathyMyocarditisCarditisPericarditis
spellingShingle Reem Sayad
Abdelmonem Siddiq
Ahmed Hashim
Ahmed Saad Elsaeidy
Can the current monkeypox affect the heart? A systematic review of case series and case report
BMC Cardiovascular Disorders
Monkeypox
Mpox
Cardiomyopathy
Myocarditis
Carditis
Pericarditis
title Can the current monkeypox affect the heart? A systematic review of case series and case report
title_full Can the current monkeypox affect the heart? A systematic review of case series and case report
title_fullStr Can the current monkeypox affect the heart? A systematic review of case series and case report
title_full_unstemmed Can the current monkeypox affect the heart? A systematic review of case series and case report
title_short Can the current monkeypox affect the heart? A systematic review of case series and case report
title_sort can the current monkeypox affect the heart a systematic review of case series and case report
topic Monkeypox
Mpox
Cardiomyopathy
Myocarditis
Carditis
Pericarditis
url https://doi.org/10.1186/s12872-023-03351-3
work_keys_str_mv AT reemsayad canthecurrentmonkeypoxaffecttheheartasystematicreviewofcaseseriesandcasereport
AT abdelmonemsiddiq canthecurrentmonkeypoxaffecttheheartasystematicreviewofcaseseriesandcasereport
AT ahmedhashim canthecurrentmonkeypoxaffecttheheartasystematicreviewofcaseseriesandcasereport
AT ahmedsaadelsaeidy canthecurrentmonkeypoxaffecttheheartasystematicreviewofcaseseriesandcasereport